Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-18,012
Closed -$45K 4529
2022
Q4
$45K Buy
18,012
+13,297
+282% +$656K ﹤0.01% 1642
2022
Q3
$10K Buy
+4,715
New +$233K ﹤0.01% 3144
2021
Q1
Sell
-94
Closed -$1K 6150
2020
Q4
$1K Sell
94
-472
-83% -$25.2K ﹤0.01% 4514
2020
Q3
$7K Sell
566
-1,037
-65% -$53.8K ﹤0.01% 3260
2020
Q2
$6K Sell
1,603
-6,036
-79% -$270K ﹤0.01% 3215
2020
Q1
$41K Sell
7,639
-1,320
-15% -$51.6K ﹤0.01% 1851
2019
Q4
$17K Buy
+8,959
New +$333K ﹤0.01% 2313
2017
Q2
Sell
-31,215
Closed -$17K 6938
2017
Q1
$17K Buy
+31,215
New +$962K ﹤0.01% 3508

Other funds holding QGEN

Cutler Group's QGEN Position: Q1 2024 in Review

Cutler Group opened a new position in Qiagen (QGEN) in Q1 2024: 778 shares worth $34K. The stake represents 0.01% of the portfolio and ranks #824 among its holdings. This is a return to the name: Cutler Group previously reported a position in QGEN as recently as Q3 2022.

Cutler Group first reported a position in QGEN in Q4 2019 and has held it in 12 quarters since. The position peaked at $590K in Q2 2020. 282 funds tracked by Wall St. Rank hold QGEN as of Q1 2024.

  • Cutler Group held 778 shares of Qiagen worth $34K as of Q1 2024.
  • Qiagen was a new Cutler Group position in Q1 2024.
  • Qiagen made up 0.01% of Cutler Group's portfolio in Q1 2024, its #824 holding.
  • Cutler Group first reported a position in Qiagen in Q4 2019 and has held it in 12 quarters since.
  • Cutler Group's Qiagen position peaked at $590K in Q2 2020.
  • 282 funds tracked by Wall St. Rank held Qiagen as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.